ZIOPHARM Oncology Inc

ZIOP:NASDAQ
RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 01/20/21 EST
3.83quote price arrow up+0.07 (+1.86%)
Volume
22,262
Close
3.76quote price arrow up+0.06 (+1.62%)
Volume
1,994,382
52 week range
1.79 - 4.66

...

Loading . . .

KEY STATS

  • Open3.73
  • Day High3.98
  • Day Low3.71
  • Prev Close3.76
  • 52 Week High4.66
  • 52 Week High Date01/21/20
  • 52 Week Low1.79
  • 52 Week Low Date03/17/20
  • Market Cap805.73M
  • Shares Out214.29M
  • 10 Day Average Volume2.61M
  • Dividend-
  • Dividend Yield-
  • Beta2.07
  • 1 Year % Change-18.97

RATIOS/PROFITABILITY

  • EPS (TTM)-0.36
  • P/E (TTM)-10.39
  • Fwd P/E (NTM)-9.24
  • EBITDA (MRQ)-72.74M
  • ROE (MRQ)-58.12%
  • Revenue (MRQ)0.00M
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-36,381.51%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date03/03/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest ZIOPHARM Oncology Inc News

There is no recent news for this security.

Latest ZIOP News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
ZIOPHARM Oncology, Inc. is a biopharmaceutical company, which is seeking to develop, acquire and commercialize, on its own or with partners, a portfolio of cancer therapies that address unmet medical needs. The Company is focused on developing products in immuno-oncology that employ gene expression, control and cell technologies to deliver cell- and viral-based therapies for the treatment of cancer and graft-versus-host-disease. It has developed an adenoviral vector...
James Huang
Chairman
Laurence Cooper M.D., Ph.D.
Chief Executive Officer
Robert Hadfield J.D.
Executive Vice President
Jill Buck
Executive Vice President
Eleanor De Groot
Executive Vice President
Address
One First Avenue Parris Building 34
, Navy Yard Plaza
Boston, MA
02129
United States